Mycobactericidal activity of bedaquiline plus rifabutin or rifampin in ex vivo whole blood cultures of healthy volunteers: A randomized controlled trial

BACKGROUND: Bedaquiline, an antimycobacterial agent approved for drug-resistant tuberculosis, is metabolized by CYP3A4, an hepatic enzyme strongly induced by rifampin, an essential part of drug-sensitive tuberculosis treatment. We examined the pharmacokinetic interactions of bedaquiline plus either...

Descripción completa

Detalles Bibliográficos
Autores principales: Wallis, Robert S., Good, Caryn E., O’Riordan, Mary A., Blumer, Jeffrey L., Jacobs, Michael R., Griffiss, J. McLeod, Healan, Amanda, Salata, Robert A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931679/
https://www.ncbi.nlm.nih.gov/pubmed/29718967
http://dx.doi.org/10.1371/journal.pone.0196756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931679/
https://www.ncbi.nlm.nih.gov/pubmed/29718967
http://dx.doi.org/10.1371/journal.pone.0196756

Ejemplares similares